HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

Market Cap	4.85B +14.3%
Revenue (ttm)	10.54B +4.1%
Net Income	136.46M -24.5%
EPS	0.24 -24.5%
Shares Out	579.89M
PE Ratio	35.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,977,000
Open	8.45
Previous Close	8.46
Day's Range	8.29 - 8.51
52-Week Range	7.12 - 18.13
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About SHA:600829

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese and Western patent medicines, Chinese herbal medicines and slices, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosmetics products. It also provides logistics services, including warehousing and distribution services; and hospital services comprising medical treatmen...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1950
• Employees: 2,735
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600829

Financial Performance

In 2025, SHA:600829's revenue was 10.38 billion, an increase of 3.29% compared to the previous year's 10.05 billion. Earnings were 133.84 million, a decrease of -37.24%.